Enrico Ascher, MD
Vascular Surgery · Brooklyn, NYNPI 1356415046
Payments from drug & device makers
Across 68 payments — averaging $563.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Angiodynamics, Inc.$35K
- W. L. Gore & Associates, Inc.$1K
- Silk Road Medical, Inc.$637
- Boston Scientific$476
- Cook Medical LLC$225
- Medtronic$136
- plus $242 from 3 others
What the payments were for
- Travel & lodging$6372%
- Food & beverage$2,5147%
- Education$22,40058%
- Other$12,80033%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Angiodynamics, Inc. | 14 | $35,200 |
| W. L. Gore & Associates, Inc. | 17 | $1,435 |
| Silk Road Medical, Inc. | 4 | $637 |
| Boston Scientific | 25 | $476 |
| Cook Medical LLC | 2 | $225 |
| Medtronic(2 entities) | 2 | $136 |
| Getinge USA Sales, LLC | 2 | $112 |
| Endologix LLC | 1 | $106 |
| Advanced Oxygen Therapy Inc. | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EVLT$19,200
- VenaCure 1470 Pro$16,000
- ENROUTE Transcarotid Neuroprotection System$605
- ENROUTE Transcarotid Stent System$605
- ENHANCE Transcarotid Peripheral Access Kit$605
- ENROUTE 0.014 Guidewire$605
- GORE VIABAHN VBX Balloon Expandable Endo$436
- Zilver PTX$225
- EXCLUDER Conformable AAA Endoprosthesis with Active Control$186
- GORE VIABAHN Endoprosthesis with Heparin$173
- ELUVIA$158
- GORE TAG Conformable Thoracic Endoprosthesis$152
- GORE VIABAHN Endoprosthesis$126
- GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis$119
- Alto Abdominal Stent Graft System$106
- VIABAHN Endoprosthesis with PROPATEN Bioactive Surface$105
How this compares
$38,351 in reported general payments places this provider in the 80th percentile of 405 vascular surgery providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 34 | $23,736 |
| XareltoRivaroxaban | 13 | $7,497 |
| Cilostazol | 27 | $268 |
| ClopidogrelClopidogrel Bisulfate | 27 | $128 |
| Ammonium Lactate | 15 | $55 |
Paid to pharmacies, not to this prescriber.
Other vascular surgery in Brooklyn
- Robert RheeBrooklyn$406K
- Nicole IlonzoBrooklyn$94K
- Michael ShapiroBrooklyn$54K
- Gary GelbfishNew York$1.9M
- Sundaram RavikumarDobbs Ferry$1.8M
- Antonios GasparisHuntington$1.7M
- John LantisNew York$1.4M
- Sonya NoorBuffalo$1.2M
- Brian DerubertisNew York$1M
- Thomas MaldonadoNew York$1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.